HONJO TASUKU has a total of 29 patent applications. Its first patent ever was published in 1985. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are PRODA BIOTECH LLC, ALEXION PHARMA INC and GILEAD BIOLOGICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | United States | 7 | |
#3 | Canada | 5 | |
#4 | Japan | 4 | |
#5 | Australia | 1 | |
#6 | Hungary | 1 | |
#7 | Luxembourg | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Engines, pumps and turbines |
# | Name | Total Patents |
---|---|---|
#1 | Honjo Tasuku | 27 |
#2 | Shibayama Shiro | 7 |
#3 | Severinson Eva | 5 |
#4 | Iwai Yoshiko | 5 |
#5 | Minato Nagahiro | 5 |
#6 | Tashiro Kei | 4 |
#7 | Tada Hideaki | 3 |
#8 | Miyamoto Masakazu | 2 |
#9 | Takatu Kiyoshi | 2 |
#10 | Takeda Kazuhiko | 2 |
Publication | Filing date | Title |
---|---|---|
JP2004033137A | Method for screening anticancer agent | |
JP2001245669A | New cytidine deaminase | |
JPH1146777A | Production of human b cell differentiation factor | |
EP0302429A1 | Novel human interleukin 4, expression vectors for human interleukin 4 and transformants containing the same | |
CA1340689C | Human b-cell differentiation factor and process of producing said factor |